Epilepsy
Conditions
Brief summary
The investigators hypothesize that the participants will be satisfied with artificial-intelligence wristband Embrace
Detailed description
Currently, seizure tracking relies on subjective patient and family recall. In several studies patients report only approximately half of their seizures, and even less during sleep. Sudden unexplained death in epilepsy (SUDEP) is the cause of premature death of up to 17% of all patients with epilepsy and as many as 50% with chronic refractory epilepsy (with rates as high as 1% per year). Its etiology is probably due to peri-ictal respiratory, cardiac, or autonomic nervous system dysfunction. Wristband sensors help caregivers assist patients during seizures and may reduce risks for complications such as injuries and SUDEP. Accurate seizure detection may improve the quality of life (QoL) of subjects and caregivers by decreasing burden of seizure monitoring and may facilitate diagnostic monitoring in the home setting. Possible risks are occurrence of alarm fatigue and invasion of privacy. The wristband Embrace has an overall sensitivity of 89.1% and an overall specificity of 93.1%. The investigators hypothesize that the participants will be satisfied with artificial-intelligence wristband Embrace. Methods: When the smart wristband detects the seizure, the mobile phone sends a text message to the companion and the nurse, the latter will see or get in touch with the companion and keep a record. In-patients receiving video-electroencephalography (VEEG) exam use Embrace during the VEEG recording which usually takes 3-5 days. Out-patients use Embrace for 8 weeks. The investigators will enroll 30-50 patients, half in-patients and half out-patients. The benefits are evaluated in terms of satisfaction. .
Interventions
DEVICEEmbrace
Patients wear Embrace2 to help in seizure reporting and patient care.
Sponsors
Taichung Veterans General Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* At least one seizure per month in the 3-month period before entering the study
Exclusion criteria
* Uncountable seizures, psychogenic seizures, alcohol or drug abuse, severe heart or lung disorder, rapid progressive brain disorder, life-terminal disease, severe infection/ bleeding/ liver/ kidney disorder, platelet \<80,000/μL, neutrophil \<1,000/μL, clinically significant ECG abnormality, unstable psychiatric disease (except anxiety).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Satisfaction score of seizure wristband | Through study completion, an average of 1 year | Scores 1(least satisfied) to 10 (most satisfied) |
Countries
Taiwan
Contacts
Primary ContactPEIYUAN F. HSIEH, MD
Outcome results
None listed